In contrast, ccRCC patients with higher expression of LNα1, LNγ1, Col 4A2, or entactin (Nidogen 1) have a better survival rate However for pRCC, survival was reduced in this case (Table 2). This evidence concerns the gene NID1 and nonpapillary renal cell carcinoma.